Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P240009/S006

Neuroguard IEP 3-in-1 Carotid Stent, Post-Dilation Balloon System with Integrated Embolic Protection

Contego Medical, Inc. · Decision date Nov 4, 2026

FDA DECISIONP240009/S006

What did the FDA approve?

FDA records P240009/S006 as a supplement to PMA P240009, with the supplement type “Panel Track”. The recorded decision is approval, dated Nov 4, 2026.

FDA approval order statement

The Neuroguard IEP Direct 3-in-1 Carotid Stent and Post-Dilation Balloon System with Integrated Embolic Protection used in conjunction with the Neuroguard IEP Embolic Protection System is indicated for improving carotid luminal diameter in subjects at high risk for adverse events from carotid endarterectomy who require carotid revascularization and meet the criteria outlined below: Patients with = 50% symptomatic stenosis of the internal carotid artery (ICA) or common carotid artery (CCA) as determined by angiography, CTA, or duplex ultrasound or patients with = 70% asymptomatic stenosis of the internal carotid artery (ICA) or common carotid artery (CCA) as determined by angiography, CTA, or duplex ultrasound Patients with a reference vessel diameter of 4.0 - 8.0 mm At least 5 cm of atherosclerosis free space in the ipsilateral common carotid artery between the sheath insertion site and the proximal edge of the target lesion. This device is also indicated for post-dilation of the stent component with simultaneous capture and removal of embolic material.
Regulatory pathway
PMA supplement
Supplement type
Panel Track
Clinical specialty
Cardiovascular
Decision date
Nov 4, 2026
FDA change category
Change Design/Components/Specifications/Material

FDA source record

Regulatory record facts

Identifier
P240009/S006
Regulatory pathway
PMA supplement
Product code
NIM
Decision code
APPR
Decision date
Nov 4, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Stent, carotid.

Product code
NIM
FDA device class
3

For the original device and its historical approval scope, see PMA P240009. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P240009 · Original PMA

    Neuroguard IEP 3-in-1 Carotid Stent, Post-Dilation Balloon System with Integrated Embolic Protection

  2. P240009/S006 received

    Application receipt date recorded by FDA.

  3. P240009/S006 · FDA decision

    Panel Track

Timeline entries are records held by MedtechLedger for P240009. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P240009

Product / regulatory recordCompanyPathwayDecision dateSource
Contego Medical, Inc.PMA approvalOct 11, 2024FDA

Explore the linked device profile

Other records with product code NIM

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Contego Medical, Inc.

Headquarters
Not reported
Brand website
contegomedical.com
FDA applicant address
3801 Lake Boone Trl., Suite 100, Raleigh, NC, 27607

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records